Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial T Crosby, CN Hurt, S Falk, S Gollins, S Mukherjee, J Staffurth, R Ray, ... The lancet oncology 14 (7), 627-637, 2013 | 431 | 2013 |
Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials A Hartley, KF Ho, C McConkey, JI Geh The British journal of radiology 78 (934), 934-938, 2005 | 256 | 2005 |
Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer JI Geh, AM Crellin, R Glynne‐Jones British journal of surgery 88 (3), 338-356, 2001 | 250 | 2001 |
Chemoradiotherapy for rectal cancer: an updated analysis of factors affecting pathological response P Sanghera, DWY Wong, CC McConkey, JI Geh, A Hartley Clinical oncology 20 (2), 176-183, 2008 | 243 | 2008 |
Cancer of the anal canal MA Clark, A Hartley, JI Geh The lancet oncology 5 (3), 149-157, 2004 | 230 | 2004 |
Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response JI Geh, SJ Bond, SM Bentzen, R Glynne-Jones Radiotherapy and oncology 78 (3), 236-244, 2006 | 213 | 2006 |
International consensus definition of low anterior resection syndrome C Keane, NS Fearnhead, L Bordeianou, P Christensen, E Espin Basany, ... Colorectal Disease 22 (3), 331-341, 2020 | 212 | 2020 |
Survival after neoadjuvant and adjuvant treatments compared to surgery alone for resectable esophageal carcinoma: a network meta-analysis S Pasquali, G Yim, RS Vohra, S Mocellin, D Nyanhongo, P Marriott, ... Annals of surgery 265 (3), 481-491, 2017 | 200 | 2017 |
Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open … SP Bach, A Gilbert, K Brock, S Korsgen, I Geh, J Hill, T Gill, P Hainsworth, ... The lancet Gastroenterology & hepatology 6 (2), 92-105, 2021 | 141 | 2021 |
Use of a modified Delphi approach to develop research priorities for the association of coloproctology of Great Britain and Ireland J Tiernan, A Cook, I Geh, B George, L Magill, J Northover, A Verjee, ... Colorectal Disease 16 (12), 965-970, 2014 | 117 | 2014 |
A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer SA Hussain, DD Stocken, P Riley, DH Palmer, DR Peake, JI Geh, ... British journal of cancer 91 (5), 844-849, 2004 | 102 | 2004 |
Review of second-line chemotherapy for advanced gastric adenocarcinoma D Wilson, L Hiller, JI Geh Clinical Oncology 17 (2), 81-90, 2005 | 79 | 2005 |
Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy+/− cetuximab in oesophageal cancer T Crosby, CN Hurt, S Falk, S Gollins, J Staffurth, R Ray, JA Bridgewater, ... British journal of cancer 116 (6), 709-716, 2017 | 78 | 2017 |
The use of chemoradiotherapy in oesophageal cancer JI Geh European Journal of Cancer 38 (2), 300-313, 2002 | 77 | 2002 |
Multicentre study of short-course radiotherapy and transanal endoscopic microsurgery for early rectal cancer CJ Smart, S Korsgen, J Hill, D Speake, B Levy, M Steward, JI Geh, ... Journal of British Surgery 103 (8), 1069-1075, 2016 | 74 | 2016 |
Ireland (ACPGBI): guidelines for the management of cancer of the colon, rectum and anus (2017)-multidisciplinary management S Gollins, B Moran, R Adams, C Cunningham, S Bach, AS Myint, ... Colorectal Dis 19 (Suppl 1), 37-66, 2017 | 68 | 2017 |
Wide variation in the use of radiotherapy in the management of surgically treated rectal cancer across the English National Health Service EJA Morris, PJ Finan, K Spencer, I Geh, A Crellin, P Quirke, JD Thomas, ... Clinical Oncology 28 (8), 522-531, 2016 | 66 | 2016 |
Association of Coloproctology of Great Britain & Ireland (ACPGBI): guidelines for the management of cancer of the colon, rectum and anus (2017)–surgical management B Moran, C Cunningham, T Singh, P Sagar, J Bradbury, I Geh, ... Colorectal Disease 19, 18-36, 2017 | 63 | 2017 |
Association of Coloproctology of Great Britain & Ireland (ACPGBI): guidelines for the management of cancer of the colon, rectum and anus (2017) I Geh, S Gollins, A Renehan, J Scholefield, V Goh, D Prezzi Anal Cancer 19, 82-97, 2017 | 57 | 2017 |
Tumour-and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus … R Glynne-Jones, L Kadalayil, HM Meadows, D Cunningham, L Samuel, ... Annals of oncology 25 (8), 1616-1622, 2014 | 54 | 2014 |